Leukemia Research
Volume 29, Issue 6 , Pages 679-683 , June 2005

Rituximab therapy of lymphoma is enhanced by orally administered (1→3),(1→4)-d-β-glucan

  • Shakeel Modak

      Affiliations

    • Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 6397623; fax: +1 212 7442245.
    • ,
  • Guenther Koehne

      Affiliations

    • Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    • ,
  • Andrew Vickers

      Affiliations

    • Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    • Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    • ,
  • Richard J. O’Reilly

      Affiliations

    • Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    • ,
  • Nai-Kong V. Cheung

      Affiliations

    • Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA

Received 20 August 2004 ,Accepted 27 October 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(04)00380-7

doi: 10.1016/j.leukres.2004.10.008

Leukemia Research
Volume 29, Issue 6 , Pages 679-683 , June 2005

Article Tools

* Image Usage & Resolution